WallStSmart
PRTC

PureTech Health PLC

NASDAQ: PRTC · HEALTHCARE · BIOTECHNOLOGY

$17.26
+0.00% today

Updated 2026-06-05

Market cap
$419.90M
P/E ratio
P/S ratio
90.13x
EPS (TTM)
$-4.60
Dividend yield
52W range
$15 – $20
Volume
0.0M

WallStSmart proprietary scores

30
out of 100
Grade: F
Strong Sell
Investment rating
7.3
Growth
B+
5.0
Quality
C+
2.5
Profitability
F
5.0
Valuation
C+
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target
$46.00
+166.51%
12-Month target
$19.23
+11.41%
Intrinsic (DCF)
Margin of safety

Price chart

Stock snapshot

Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-38.48M
- Revenue declining -38.20% QoQ

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$2.09M$3.33M$4.83M$4.66M$4.66M
Net income$-50.35M$-65.70M$53.51M$-109.74M$-64.89M
EPS$-4.60
Free cash flow$-180.97M$-106.16M$-134.38M$-85.34M$-38.48M
Profit margin-2,409.33%-1,972.88%1,108.33%-2,355.42%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
PRTC$419.90M307.32.55.05.0Avoid
LLY$948.95B7810.010.05.06.0Strong Buy
JNJ$536.54B594.79.03.36.0-71.41%Buy
ABBV$380.57B634.08.04.05.0-55.64%Buy
UNH$343.21B545.35.54.75.5-26.61%Buy
MRK$285.64B503.38.02.75.0-49.34%Hold

Smart narrative

PureTech Health PLC trades at $17.26. Our Smart Value Score of 30/100 indicates the stock is weak. TTM revenue stands at $4.66M.

Frequently asked questions

What is PureTech Health PLC's stock price?

PureTech Health PLC (PRTC) trades at $17.26, on a P/S of 90.1x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.

Is PureTech Health PLC overvalued?

PureTech Health PLC carries a Smart Value Score of 30/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of PureTech Health PLC (PRTC)?

The 12-month analyst consensus target is $46.00, about 166.5% above the current $17.26. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

What is PureTech Health PLC's revenue?

PureTech Health PLC's trailing twelve-month revenue is $4.66M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio90.13x
ROE-30.80%
Beta0.79
50D MA$16.85
200D MA$17.24
Shares out0.02B
Float0.16B
Short ratio
Avg volume0.0M

Performance

1 week+0.00%
1 month-3.01%
3 months+4.69%
YTD+4.69%
1 year
3 years
5 years